image
Athira Pharma, Inc. ATHA
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 0.431
3.82 %
$ 16.8 M
Market Cap
-0.2
P/E
Price Target Average
--100.00%
Revenue Forecast Estimate
-0.00%
EBIT Estimate
18.92%
Net Income Estimate
62.47%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Athira Pharma, Inc.
image
ATHA has no price targets from Wall Street.
REVENUE FORECAST

Revenue Forecast Chart ATHA

image
$14.0m$14.0m$12.0m$12.0m$10.0m$10.0m$8.0m$8.0m$6.0m$6.0m$4.0m$4.0m$2.0m$2.0m$0.0$0.020232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart ATHA

image
$0.0$0.0($20.0m)($20.0m)($40.0m)($40.0m)($60.0m)($60.0m)($80.0m)($80.0m)($100.0m)($100.0m)($120.0m)($120.0m)20232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart ATHA

image
$0.0$0.0($20.0m)($20.0m)($40.0m)($40.0m)($60.0m)($60.0m)($80.0m)($80.0m)($100.0m)($100.0m)($120.0m)($120.0m)($140.0m)($140.0m)20232023202420242025202520262026202720272028202820292029